Manual vs. automated: the diabetic retinopathy screening debate

Article

Systematic screening for diabetic retinopathy (DR) has been identified as a cost-effective use of health service resources,1-4 with national screening programmes based on digital photography being implemented across Europe. In Scotland, images are captured at local screening centres and sent electronically to one of nine regional grading centres, where they are manually graded using a three-level system (Figure 1).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.